© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
Home 2014
Archives
Healthcare immunization: Protecting coworkers and the community
Health care professionals are at high risk for exposure to vaccine-preventable diseases and infections. Safeguard yourself, your patients, and your family members. Make sure...
FDA approves new product to treat hereditary angioedema
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks...
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
New intravaginal ring
Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a...
Chemotherapy and Biotherapy Drugs for Autoimmune Disease
New biotherapy drugs and older chemotherapy agents may improve quality of life in patients with autoimmune diseases.
Updated guidelines for managing occupational HIV exposure released
Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations...
Study: Poor sleep in pregnancy may contribute to birth-related complications
Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and may lead to lower birth weights and other complications, according to...
Be prepared for poison ivy, oak, and sumac
The author clears up misconceptions and discusses treatment.
Soothing the sorrow of psoriasis
You can help patients suffering from this chronic skin disease.
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral...
FDA approves Xeljanz for rheumatoid arthritis
On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who...
FDA approves new MS drug
On Sept. 12, the U.S. Food and Drug Administration (FDA) approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms...